Medical Technology Current Affairs - 2019
Category Wise PDF Compilations available at This Link
The US Food and Drug Administration (FDA) has approved use of Acuvue Oasys Contact Lenses with Transitions Light Intelligent Technology, world’s first contact lens that automatically darkens when exposed to bright light. It is first of its kind contact lens to incorporate same technology that is used in eyeglasses that automatically darken in the sun.
These contact lens are soft contact lenses indicated for daily use to correct vision of people with non-diseased eyes who are nearsighted (myopic) or farsighted (hyperopic). They can be used by people with certain degrees of astigmatism, an abnormal curvature of the eye.
These contact lenses contain photochromic additive that adapts amount of visible light filtered to eye based on amount of ultra-violet (UV) light to which they are exposed. This additive slightly darkens lenses in bright sunlight that automatically return to regular tint when exposed to normal or dark lighting conditions.
Tags: Acuvue Oasys Contact Lenses • Medical Technology • Science and Technology • Transitions Light Intelligent Technology • USFDA
Government has launched Noxeno, a nasal foreign body removal device developed by start-up InnAccel Technologies Private Limited, Bangalore. It was developed by fellow trained under Biodesign program. Noxeno is It is first dedicated tool for anterior nasal foreign body (NFB) removal that allows doctors in any setting to quickly and safely remove objects that people (mostly children aged 2 to 10 years) put into their noses.
Noxeno has been 100% invented, designed, engineered and manufactured in India. It has ergonomic handle along with built-in light source and hinge. This allows user to slip behind NFB and remove it in matter of seconds by simply squeezing the trigger and pulling the device.
The modular nature of the system allows for sterilization of hinge through autoclaving it. It is reusable device and is also both easy to use and cost-effective. InnAccel Technologies is hoping to deploy this device across primary health care centres (PHCs), community health care centres (CHCs), clinics and smaller hospitals nationwide by 2020.